Hearing EF Hutton Initiates Coverage On Bone Biologics With Buy Rating And $2.25 Price Target
BenzingaMay 31, 2023 16:52 ET
EF Hutton Reiterates Buy on Bone Biologics, Maintains $2.25 Price Target
BenzingaApr 13, 2023 07:03 ET
EF Hutton Reiterates Buy on Bone Biologics, Maintains $2.25 Price Target
BenzingaApr 3, 2023 10:12 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (ARGX), Roche Holding AG (OtherRHHVF) and Bone Biologics (BBLG)
TipRanksOct 18, 2022 09:10 ET
Bone Biologics Analyst Ratings
Benzinga Analyst RatingsOct 18, 2022 07:48 ET
EF Hutton Initiates Coverage On Bone Biologics With Buy Rating, Announces Price Target of $2.25
Benzinga Real-time NewsOct 18, 2022 07:48 ET
No Data
No Data